In addition to the widely studied effects of DES, another non-steroidal oestrogen potentially implicated in BC and PC increased risk is the mycotoxin zearalenone (ZEA), which has been found to exert its effects on both ER and GPER [118]. Here, ESR1 is linked to breast cancer.